BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1555790)

  • 1. [Treatment and prevention of the ovarian hyperstimulation syndrome].
    Morán C; Ortega E; Fiorelli S; Murillo A; Zárate A
    Ginecol Obstet Mex; 1992 Jan; 60():4-7. PubMed ID: 1555790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between circulating androgens and ovarian hyperstimulation syndrome in anovulatory patients treated with hMG-hCG].
    Takahashi H; Inui Y; Mimura T; Kato H; Yamano S; Oono Y; Takeuchi S; Ezaki Y; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2163-71. PubMed ID: 6818311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovarian hyperstimulation syndrome].
    Keck C; Neulen J; Breckwoldt M
    Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):315-20. PubMed ID: 8088486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
    Tulandi T; McInnes RA; Arronet GH
    Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian hyperstimulation in medically assisted reproduction: which practical approach?].
    Priou G
    Contracept Fertil Sex; 1996 Sep; 24(9):647-9. PubMed ID: 8998510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian hyperstimulation syndrome in gonadotropin-treated laboratory South African clawed frogs (Xenopus laevis).
    Green SL; Parker J; Davis C; Bouley DM
    J Am Assoc Lab Anim Sci; 2007 May; 46(3):64-7. PubMed ID: 17487957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovarian hyperstimulation syndrome in medically assisted reproduction].
    Rogé P; Erny R
    Rev Fr Gynecol Obstet; 1994 Oct; 89(10):495-501. PubMed ID: 7817078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound evaluation of the ovarian hyperstimulation syndrome.
    Painvain E; Barlese MG; Mastrojanni F; Bolzano G; Gaglione R; Dragone L; Ferrarotti M; Taramanni C
    Acta Eur Fertil; 1987; 18(1):39-43. PubMed ID: 3115025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating infertility. Controlled ovarian hyperstimulation using human menopausal gonadotropin in combination with intrauterine insemination.
    Vollenhoven B; Selub M; Davidson O; Lefkow H; Henault M; Serpa N; Hung TT
    J Reprod Med; 1996 Sep; 41(9):658-64. PubMed ID: 8887190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple organ failure syndrome after ovarian hyperstimulation].
    Diatta B; Petrognani R; Angel G; Marquine C; Eliet J; Seck M; Seignot P
    Med Trop (Mars); 1997; 57(4):373-4. PubMed ID: 9612780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The ovarian hyperstimulation syndrome. Institutional experience].
    Serviere Zaragoza C; Camarero García A; Carranza Lira S; Kably Ambe A
    Ginecol Obstet Mex; 1994 Oct; 62():292-5. PubMed ID: 7995541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovulation induction with human menopausal gonadotropins in hypothalamic-hypophyseal disfunction].
    Ibarra Chavarria V; Mota Gonzalez M; Carballar Lopez G; Espinosa de los Monteros A; Karchmer S
    Ginecol Obstet Mex; 1993 Jul; 61():195-200. PubMed ID: 8349134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome. A case report.
    Rabinerson D; Ben Rafael Z; Keslin J; Zolotarsky V; Dekel A
    J Reprod Med; 2001 Jan; 46(1):68-70. PubMed ID: 11209636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anesthetic management of a patient with severe ovarian hyperstimulation syndrome].
    Kawamura G; Ito N; Hanaoka K; Yamada Y
    Masui; 2009 Mar; 58(3):360-2. PubMed ID: 19306640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous ovarian hyperstimulation in a naturally conceived pregnancy with uncontrolled hypothyroidism.
    Edwards-Silva RN; Han CS; Hoang Y; Kao LC
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):498-501. PubMed ID: 18238999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy.
    Aboulghar MA; Mansour RT; Serour GI; Sattar MA; Amin YM; Elattar I
    Obstet Gynecol; 1993 Jan; 81(1):108-11. PubMed ID: 8416442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.